Myelodysplastic Syndromes (MDS) are a collection of disorders in which blood cells remain at an immature stage within the bone marrow and never fully develop into cells capable of performing their necessary functions. MDS patients do not meet criteria for leukemia based on the percentage of blasts in the bone marrow. However, many MDS patients will eventually develop AML over time, leading to use of the terms “smoldering leukemia” and “preleukemia” to describe this condition.
Also called pre-leukemia. A group of disorders in which the bone marrow does not function normally and not enough normal blood cells are made.
Preleukemic conditions characterized by bone marrow or hematopoietic dysfunction and manifested as anemia, neutropenia, thrombocytopenia or a combination of these disorders.
also known as 'smoldering' or preleukemia, a group of diseases in which the bone marrow does not function normally, and insufficient numbers of mature blood cells are in circulation. Bone marrow failure can result in death from bleeding and infection in the majority of patients, while transformation to acute leukemia occurs in up to 40% of patients.
Diseasesin which the bone marrow does not function normally and not enough normal blood cells are made. Also called pre-leukemia or "smoldering" leukemia.
A group of disorders characterized by low white blood cell counts, low platelet counts, and, in some cases, increased monocytes. The primary problem is in the bone marrow cellularity.
Conditions that result when blood cells fail to form or reproduce normally.
a disease in which the bone marrow produces new blood cells, but those cells are dysfunctional and insufficiently developed
Conditions in which the bone marrow shows qualitative and quantitative changes suggestive of a preleukemic process, but having a chronic course that does not necessarily terminate as acute leukemia.